Neu siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemNeu siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-29405
Quantity10 µM
Specieshuman
NCBI Full Gene Nameerb-b2 receptor tyrosine kinase 2
NCBI Gene AliasesCD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19, NEU, NGL, TKR1, VSCN2, c-ERB-2, c-ERB2, p185(erbB2)
TypesiRNA/dsRNA
Gene Namev-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) N-phenylquinazolin-4-amine-based EGFR TKIs suppress pulmonary fibrosis by modulating the EGFR/ERBB3 axis in epithelial-macrophage interactionCommun BiolDecember 1, 2025Ji-Hee Kim, Seo-Hyun Choi, Jae-Kyung Nam, Min-Sik Park, Haeng Ran Seo, Inhee Choi, Hae-June Lee, Jaeho Cho, Jeeyong Lee, Yoon-Jin Leetransfection reagent, and EGFR siRNA (Santa Cruz Biotechnology; #sc-29301), ERBB2 siRNA (Santa Cruz Biotechnology; #sc-29405) ERBB3 siRNA (Santa Cruz Biotechnology; #sc-35327), ERBB4 siRNA (Santa Cruz Biotechnology; #sc-35329),

(2) An Orally Available Grafted Peptide Targeting Epidermal Growth Factor Receptor Dimers Reduces Non-Small Cell Lung Cancer Tumors in Mouse ModelsACS Pharmacology & Translational ScienceOctober 10, 2025Prajesh Shrestha, Sitanshu S. Singh, Achyut Dahal, Vivitri Prasasty, Arpan Chowdhury, Debajyoti Majumdar, Xin Gu, William Johnson, Dachuan Zhang, Daniel D. Billadeau, et al.dimerization. Calu-3 cells were transfected with siRNA control (Santa Cruz, sc-37007), HER2 siRNA (Santa Cruz, sc-29405) using Lipofectamine 2000 (Thermo-fischer, 11668027). qPCR was performed to measure the HER2 gene expression

(3) Pyrotinib targeted EGFR/GRP78 mediated cell apoptosis in high EGFR gene copy number gastric cancerJ Exp Clin Cancer ResAugust 19, 2025Lingbo Bao, Xudong Wang, Xiuyong Liao, Dong Li, ChunXue Li, Nan Dai, Xiaoyan Dai, Jing Yang, Nana Hu, Xueling Tong, et al.harvested and analyzed protein expression by western blotting. The siRNA for EGFR (sc-29301), HER2 (sc-29405) and HER4 (sc-35329) were acquired from Santa Cruz. The GRP78 siRNA was acquired from Genepharma and

(4) AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer CellsCancersJune 21, 2022Jeong S, Farag AK, Yun HK, Jeong YA, Kim DY, Jo MJ, Park SH, Kim BR, Kim JL, Kim BG, et al.

(5) Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling PathwayMolecular cancer therapeuticsOctober 1, 2021Zhang W, Bhagwath AS, Ramzan Z, Williams TA, Subramaniyan I, Edpuganti V, Kallem RR, Dunbar KB, Ding P, Gong K, et al.transfected with either a nontargeting control (SC-37007, Santa Cruz Biotechnology) or ERBB2 targeting siRNA (SC-29405, Santa Cruz Biotechnology) using Lipofectamine LTX (Thermo Fisher Scientific). Cells were transfected

(6) Erb-b2 Receptor Tyrosine Kinase 2 (ERBB2) Promotes ATG12-Dependent Autophagy Contributing to Treatment Resistance of Breast Cancer CellsCancersMarch 2, 2021Chen Y, Wang R, Huang S, Henson ES, Bi J, Gibson SB.Inc. (Logan, UT, USA). The Control siRNA-A (siCon) (Sc-37007), the siRNAs against ERBB2 (siERBB2) (sc-29405) and ATG12 (siATG12) (sc-72578), ERBB2 double nickase plasmid (sc-400138-NIC) (NIC-ERBB2) and the control

(7) Erb‑B2 Receptor Tyrosine Kinase 2 is negatively regulated by the p53‑responsive microRNA‑3184‑5p in cervical cancer cellsOncology reportsJanuary 1, 2021Liu H, Li Y, Zhang J, Wu N, Liu F, Wang L, Zhang Y, Liu J, Zhang X, Guo S, et al.additional 48 h prior to subsequent experimentation. siRNAs targeting human ERBB2 (ERBB2-siRNA; cat. no. sc-29405), human PIK3CA (PIK3CA-siRNA; cat. no. sc-39127) and scrambled control (scr-siRNA; cat. no. sc-37007)

(8) Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cellsRadiation oncology (London, England)March 6, 2020Tien Y, Tsai CL, Hou WH, Chiang Y, Hsu FM, Tsai YC, Cheng JC.

(9) Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancerBritish journal of cancerFebruary 1, 2019Li Z, Liao J, Yang Z, Choi EY, Lapidus RG, Liu X, Cullen KJ, Dan H.

(10) Algal photoprotection is regulated by the E3 ligase CUL4-DDB1^DET1Nature plantsJanuary 1, 2019Aihara Y, Fujimura-Kamada K, Yamasaki T, Minagawa J.

(11) Dual Targeting of ERBB2/ERBB3 for the Treatment of SLC3A2-NRG1-Mediated Lung CancerMolecular cancer therapeuticsSeptember 1, 2018Shin DH, Jo JY, Han JY.

(12) A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382OncogenesisJuly 30, 2018Wang B, Li D, Filkowski J, Rodriguez-Juarez R, Storozynsky Q, Malach M, Carpenter E, Kovalchuk O.

(13) Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatmentCancer lettersDecember 28, 2017Shu T, Li Y, Wu X, Li B, Liu Z.

(14) MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progressionOncogeneJanuary 26, 2017Khan S, Sikander M, Ebeling MC, Ganju A, Kumari S, Yallapu MM, Hafeez BB, Ise T, Nagata S, Zafar N, et al.

(15) Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cellsCell death & diseaseJuly 21, 2016Ma S, Henson ES, Chen Y, Gibson SB.cocktail (ref no. 11 836 153 001) from Roche Diagnostics (Basel, Switzerland). The siRNA against HER2 (sc-29405), EGFR (sc-44340), transferrin (sc-37176), ferroportin (sc-60663), XCT (sc-76933) and Control siRNA-A

(16) β2-AR signaling controls trastuzumab resistance-dependent pathwayOncogeneJanuary 7, 2016Liu D, Yang Z, Wang T, Yang Z, Chen H, Hu Y, Hu C, Guo L, Deng Q, Liu Y, et al.

(17) Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer CellsMolecular cancer therapeuticsMarch 1, 2015Tsai YC, Ho PY, Tzen KY, Tuan TF, Liu WL, Cheng AL, Pu YS, Cheng JC.

(18) Furanodienone induces cell cycle arrest and apoptosis by suppressing EGFR/HER2 signaling in HER2-overexpressing human breast cancer cellsCancer chemotherapy and pharmacologyNovember 1, 2011Li YW, Zhu GY, Shen XL, Chu JH, Yu ZL, Fong WF.

(19) Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cellsThe Journal of biological chemistryNovember 12, 2010Long JS, Fujiwara Y, Edwards J, Tannahill CL, Tigyi G, Pyne S, Pyne NJ.

(20) MicroRNA-21 is involved in ionizing radiation-promoted liver carcinogenesisInternational journal of clinical and experimental medicineJuly 31, 2010Zhu Y, Yu X, Fu H, Wang H, Wang P, Zheng X, Wang Y.

Be the First to Write a Review!

Neu siRNA (h)

Neu siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (23)

Reviews

Neu siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map